Hyperion Therapeutics Inc.
Funding rounds
4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2014 | $8 M | Issued in a merger or acquisition | $2 to $10 million | equity | SEC | |
| Oct 2011 | $8 M | No. 4 | $2 to $10 million | equity, debt, options | SEC | |
| Apr 2011 | $17 M | No. 3 | $10 to $50 million | equity, debt, options | SEC | |
| Jun 2009 | $22 M | No. 2 | $10 to $50 million | equity | SEC | |
| Aug 2008 | $13 M | No. 1 | $10 to $50 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Hyperion Therapeutics Inc. had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Jun 2014).
SEC Form D (revenue range) · Jun 2014
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jun 2014
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
18 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Bay City Capital Fund V Co-Investment Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Bay City Capital Fund V, L.P. | Fund or asset manager | not stated | not stated | Held Series C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Bay City Capital LLC | Fund or asset manager | not stated | not stated | Held Series C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Bay City Capital Management V LLC | Fund or asset manager | not stated | not stated | Held Series C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Christine A. Nash | Person | not stated | not stated | Held Series C-1 preferred stock (Form 3, 2012) | SEC Form 3 |
| Highland Capital Partners VII-B L.P. | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Highland Capital Partners VII-C LP | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Highland Capital Partners VII LP | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Highland Entrepreneurs Fund VII Limited Partnership | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Highland Management Partners VII Limited Partnership | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Highland Management Partners VII, LLC | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Klara Dickinson | Person | not stated | not stated | Held Series C-1 preferred stock (Form 3, 2012) | SEC Form 3 |
| Nea 12 GP, LLC | Other | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| NEA Partners 12, Limited Partnership | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| New Enterprise Associates 12, Limited Partnership | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Panorama Capital, L.P. | Fund or asset manager | not stated | not stated | Held Series C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Sofinnova Management VII, L.L.C. | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Sofinnova Venture Partners VII L.P. | Venture capital | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 12 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Ashley A. Gould | Executive officer | Jun 2014 |
| Bruce F. Scharschmidt | Executive officer | Jun 2014 |
| Christine A. Nash | Executive officer | Jun 2014 |
| Donald J. Santel | Executive officer | Jun 2014 |
| Jeffrey S. Farrow | Executive officer | Jun 2014 |
| Klara A. Dickinson | Executive officer | Jun 2014 |
| Natalie A. Holles | Executive officer | Jun 2014 |
| Bruce Scharschmidt | Executive officer | Nov 2011 |
| Christine Nash | Executive officer | Nov 2011 |
| Donald Santel | Executive officer | Nov 2011 |
| Jeffrey Farrow | Executive officer | Nov 2011 |
| Klara Dickinson | Executive officer | Nov 2011 |
| Dion Coakley | Executive officer | Apr 2011 |
| Masoud Mokhtarani | Executive officer | Apr 2011 |
| Toni Martinez | Executive officer | Jul 2009 |
| Don Santel | Executive officer | May 2009 |
| Bijan R. Salehizadeh | Director | Jun 2014 |
| Bo Jesper I. Hansen | Director | Jun 2014 |
| Daniel G. Welch | Director | Jun 2014 |
| Jake R. Nunn | Director | Jun 2014 |
| James I. Healy | Director | Jun 2014 |
| Lota S. Zoth | Director | Jun 2014 |
| Bijan Salehizadeh | Director | Nov 2011 |
| Bo Jesper Hansen | Director | Nov 2011 |
| David Gryska | Director | Nov 2011 |
| Donald Santel | Director | Nov 2011 |
| Gaurav Aggarwal | Director | Nov 2011 |
| Jake Nunn | Director | Nov 2011 |
| James Healy | Director | Nov 2011 |
| Lota Zoth | Director | Nov 2011 |
| Robert Hopfner | Director | Nov 2011 |
| Rob Hopfner | Director | Apr 2011 |
| Daniel Perez | Director | Jul 2009 |
| Jim Healy | Director | Jul 2009 |